Drug (Placebo)
Drug (Placebo) is a pharmaceutical drug with 13 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
4
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
90.0%
9 of 10 finished
10.0%
1 ended early
2
trials recruiting
13
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effect of Lidocaine on Hemodynamic Response and Postoperative Sore Throat
Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF)
Phase III Clinical Study of Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease
E-B-FAHF-2, Multi OIT and Xolair for Food Allergy
A Safety Study of Two Dapivirine (TMC120) Vaginal Gels in the United States
Clinical Trials (13)
Effect of Lidocaine on Hemodynamic Response and Postoperative Sore Throat
Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF)
Phase III Clinical Study of Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease
E-B-FAHF-2, Multi OIT and Xolair for Food Allergy
A Safety Study of Two Dapivirine (TMC120) Vaginal Gels in the United States
A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction
A Study to Assess The Effects Of Effexor XR On Cardiac Repolarization In Healthy Adult Subjects
Study to Evaluate The Effect Of Sertraline on the Cardiac Repolarization in Healthy Subjects
Evaluation of Safety of Repeated Doses of OP0201 Metered Dose Inhaler Compared to Placebo in Healthy Adult Volunteers
Evaluation of Safety and Pharmacodynamics of OP0201 Compared to Placebo in Healthy Adults
Efficacy of Oral Trigonella Foenum-graecum Seed Extract Vs Placebo in Treatment of None Alcoholic Fatty Liver Disease
Dose Ranging Study
Impact of Vitamin A on Multiple Sclerosis (MS)
All 13 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 13